BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,099 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $639,733 | -23.6% | 19,034 | -1.0% | 0.00% | -50.0% |
| Q1 2024 | $837,413 | +8.9% | 19,229 | -3.3% | 0.00% | 0.0% |
| Q4 2023 | $769,105 | +12.7% | 19,894 | +10.1% | 0.00% | 0.0% |
| Q3 2023 | $682,206 | -71.8% | 18,076 | -66.0% | 0.00% | -33.3% |
| Q2 2023 | $2,418,685 | -26.7% | 53,088 | -34.8% | 0.00% | -25.0% |
| Q1 2023 | $3,300,032 | +151.6% | 81,362 | +98.7% | 0.00% | 0.0% |
| Q4 2022 | $1,311,369 | -46.9% | 40,951 | -10.7% | 0.00% | -42.9% |
| Q3 2022 | $2,471,000 | -16.0% | 45,879 | +0.2% | 0.01% | -12.5% |
| Q2 2022 | $2,942,000 | -17.2% | 45,804 | -0.1% | 0.01% | 0.0% |
| Q1 2022 | $3,555,000 | -22.7% | 45,852 | -14.4% | 0.01% | -20.0% |
| Q4 2021 | $4,599,000 | +26.8% | 53,570 | +18.8% | 0.01% | +25.0% |
| Q3 2021 | $3,627,000 | -3.4% | 45,095 | -3.3% | 0.01% | -11.1% |
| Q2 2021 | $3,753,000 | -5.0% | 46,621 | -0.4% | 0.01% | -10.0% |
| Q1 2021 | $3,949,000 | +5.1% | 46,817 | -0.0% | 0.01% | 0.0% |
| Q4 2020 | $3,758,000 | -0.7% | 46,830 | -0.5% | 0.01% | -16.7% |
| Q3 2020 | $3,786,000 | +13.6% | 47,077 | +21.6% | 0.01% | -25.0% |
| Q2 2020 | $3,332,000 | -26.7% | 38,704 | -30.9% | 0.02% | -15.8% |
| Q1 2020 | $4,545,000 | -7.0% | 55,989 | -4.3% | 0.02% | +18.8% |
| Q4 2019 | $4,889,000 | -5.1% | 58,475 | -0.7% | 0.02% | -11.1% |
| Q3 2019 | $5,151,000 | -4.8% | 58,889 | -10.9% | 0.02% | -5.3% |
| Q2 2019 | $5,411,000 | -7.9% | 66,079 | -8.5% | 0.02% | -17.4% |
| Q1 2019 | $5,874,000 | +26.4% | 72,235 | +2.3% | 0.02% | +9.5% |
| Q4 2018 | $4,647,000 | -13.8% | 70,595 | +1.0% | 0.02% | +5.0% |
| Q3 2018 | $5,389,000 | +12.6% | 69,901 | +7.8% | 0.02% | 0.0% |
| Q2 2018 | $4,788,000 | +14.4% | 64,839 | +0.8% | 0.02% | +11.1% |
| Q1 2018 | $4,184,000 | +10.7% | 64,346 | +10.0% | 0.02% | +12.5% |
| Q4 2017 | $3,781,000 | +3.7% | 58,491 | +0.7% | 0.02% | -5.9% |
| Q3 2017 | $3,645,000 | +128.5% | 58,108 | +120.6% | 0.02% | +70.0% |
| Q2 2017 | $1,595,000 | +22.6% | 26,345 | +5.0% | 0.01% | +25.0% |
| Q1 2017 | $1,301,000 | +20.7% | 25,089 | +3.2% | 0.01% | +14.3% |
| Q4 2016 | $1,078,000 | -21.1% | 24,321 | -15.3% | 0.01% | -22.2% |
| Q3 2016 | $1,367,000 | +33.1% | 28,727 | +26.6% | 0.01% | +28.6% |
| Q2 2016 | $1,027,000 | +9.3% | 22,692 | -0.8% | 0.01% | 0.0% |
| Q1 2016 | $940,000 | -3.0% | 22,868 | -10.0% | 0.01% | -12.5% |
| Q4 2015 | $969,000 | -12.0% | 25,400 | -24.2% | 0.01% | -11.1% |
| Q3 2015 | $1,101,000 | -48.5% | 33,502 | +9.5% | 0.01% | -43.8% |
| Q2 2015 | $2,138,000 | -49.3% | 30,589 | -50.3% | 0.02% | -48.4% |
| Q1 2015 | $4,216,000 | +42.1% | 61,553 | +52.0% | 0.03% | +34.8% |
| Q4 2014 | $2,967,000 | +54.9% | 40,489 | +51.7% | 0.02% | +53.3% |
| Q3 2014 | $1,915,000 | +1.3% | 26,682 | +2.1% | 0.02% | 0.0% |
| Q2 2014 | $1,890,000 | -3.2% | 26,142 | -2.0% | 0.02% | -11.8% |
| Q1 2014 | $1,952,000 | – | 26,667 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 16,850,000 | $1,473,870,000 | 17.51% |
| SECTOR GAMMA AS | 472,305 | $41,313,000 | 6.98% |
| TSFG, LLC | 91,132 | $7,971,000 | 6.10% |
| Veritas Asset Management LLP | 6,386,849 | $558,658,000 | 5.44% |
| Palmer Knight Co | 64,636 | $5,654,000 | 4.80% |
| Triodos Investment Management BV | 193,700 | $16,943,000 | 4.30% |
| Progressive Investment Management Corp | 82,216 | $7,191,000 | 3.85% |
| Alphinity Investment Management Pty Ltd | 362,173 | $31,679,000 | 3.65% |
| HealthCor Management, L.P. | 1,032,820 | $90,341,000 | 3.42% |
| Sivik Global Healthcare LLC | 75,000 | $6,560,000 | 3.31% |